VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 143 filers reported holding VIKING THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.37 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,448,918 | -30.1% | 130,888 | +2.4% | 0.00% | 0.0% |
| Q2 2023 | $2,072,108 | +648.1% | 127,829 | +38.2% | 0.00% | – |
| Q1 2022 | $277,000 | -44.7% | 92,483 | -15.1% | 0.00% | -100.0% |
| Q4 2021 | $501,000 | -27.2% | 108,882 | -0.6% | 0.00% | 0.0% |
| Q3 2021 | $688,000 | +8.2% | 109,528 | +3.2% | 0.00% | 0.0% |
| Q2 2021 | $636,000 | -12.4% | 106,150 | -7.5% | 0.00% | 0.0% |
| Q1 2021 | $726,000 | +7.2% | 114,751 | -4.6% | 0.00% | 0.0% |
| Q4 2020 | $677,000 | +9.0% | 120,261 | +12.7% | 0.00% | 0.0% |
| Q3 2020 | $621,000 | -28.7% | 106,683 | -11.7% | 0.00% | 0.0% |
| Q2 2020 | $871,000 | +70.1% | 120,772 | +10.4% | 0.00% | 0.0% |
| Q1 2020 | $512,000 | -36.6% | 109,358 | +8.7% | 0.00% | 0.0% |
| Q4 2019 | $807,000 | +17.8% | 100,608 | +1.0% | 0.00% | 0.0% |
| Q3 2019 | $685,000 | -10.1% | 99,622 | +8.5% | 0.00% | 0.0% |
| Q2 2019 | $762,000 | -1.4% | 91,819 | +18.1% | 0.00% | 0.0% |
| Q1 2019 | $773,000 | +39.0% | 77,757 | +6.9% | 0.00% | 0.0% |
| Q4 2018 | $556,000 | -29.0% | 72,740 | +61.9% | 0.00% | -50.0% |
| Q3 2018 | $783,000 | +98.2% | 44,941 | +7.9% | 0.00% | +100.0% |
| Q2 2018 | $395,000 | – | 41,637 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| APIS CAPITAL ADVISORS, LLC | 148,000 | $1,638,360 | 2.12% |
| Sio Capital Management, LLC | 595,002 | $6,586,672 | 2.04% |
| 5AM Venture Management, LLC | 585,000 | $6,475,950 | 1.86% |
| Artia Global Partners LP | 383,580 | $4,246,231 | 1.76% |
| Integral Health Asset Management, LLC | 800,000 | $8,856,000 | 1.23% |
| Boxer Capital, LLC | 2,000,000 | $22,140,000 | 1.18% |
| DAFNA Capital Management LLC | 319,655 | $3,538,581 | 1.10% |
| Affinity Asset Advisors, LLC | 332,600 | $3,681,882 | 1.04% |
| MPM BioImpact LLC | 325,000 | $3,597,750 | 0.96% |
| Affinity Asset Advisors, LLC | 300,000 | $3,321,000 | 0.93% |